Pasar al contenido principal

BIOIMPRESION DE UN TUMOR-EN-UN-CHIP 4D PARA EL CRIBADO DE FARMACOS USANDO BIOTINTAS DE MATRIX EXTRACELULAR

PID2023-147892OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Biomimetic core-shell breast cancer models using alginate, gelatin, and collagen I: simulating the tumor matrix for drug evaluation

  • Gato Díaz, Uxía
  • Castro Alves, Lisandra de
  • Concheiro Nine, Ángel Joaquín
  • Piñeiro Redondo, Yolanda
  • Álvarez Lorenzo, Carmen
  • Blanco Fernández, Bárbara
  • Rivas Rey, José
Breast cancer remains among the most prevalent cancers in women worldwide. During tumor development, the extracellular matrix is altered to support tumor progression and therapy resistance. Therefore, there is a need to develop breast cancer models that replicate the complex tumor extracellular matrix to accurately mimic the mechanisms by which it influences drug resistance and cancer cell malignancy. In this study, we fabricated an innovative breast cancer 3D in vitro model consisting of core-shell hydrogel beads from alginate, gelatin, and collagen I by extrusion through a coaxial needle. Breast cancer cells proliferated in the core of all prototypes designed, forming spheroids and cell aggregates with a high resistance to doxorubicin. The addition of Collagen I to the developed model enabled the upregulation of malignancy markers (Col1A1, Ki67, FOXC2, SNAI1, NFKB1, WWTR1), invasion markers (WASL, ACTA1, MYO1E, TPM4, PODXL, ITGA2, ITGA5, MENA, EGFR, CDC42), and drug resistance markers (ABCG2, CYP1A1, BAX, HSP90AA1) occurring in vivo. The developed 3D in vitro model can clarify the contribution of the extracellular matrix to the tumor outcome and drug efficacy by replicating some key characteristics of breast tumors, establishing a novel tool for chemotherapeutic agents and drug screening.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

A 3D Bioprinted Pancreatic Cancer Model Using Collagen-Gelatin Methacrylamide-Alginate Bioinks to Mimic the Desmoplastic Microenvironment

  • Gato Díaz, Uxía
  • Blanco García, Sandra
  • Peixoto, Diana
  • Concheiro Nine, Ángel Joaquín
  • Álvarez Lorenzo, Carmen
  • Blanco Fernández, Bárbara
Pancreatic ductal adenocarcinoma is one of the cancers with the least favorable survival prognosis worldwide. It is characterized by a high desmoplastic stroma rich in collagen I, which regulates pancreatic cancer cells’ behavior. There is a critical need to develop desmoplastic 3D models for preclinical testing. In this study, bioinks that imitate the biochemical characteristics of pancreatic ductal adenocarcinoma were developed to observe the influence that the desmoplastic extracellular matrix has on cancer cells. The bioinks were made of gelatin methacrylamide, alginate, and different concentrations of collagen I. Cancer cells were able to proliferate in all bioinks, presenting high paclitaxel resistance and a high expression of desmoplasia and extracellular matrix remodeling markers. The designed bioinks can play a crucial role in developing more clinically relevant cancer models for chemotherapeutic drug screening. Furthermore, they have significant potential for studying the influence of desmoplasia and for improving advanced treatment approaches for pancreatic cancer.